MLchartDataset catalogue

Hetastarch

Term · Oncology and biomedicine · MLC-T-ONC-014112

A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous administration, hydroxyethyl starch colloid increases blood volume and thus improves circulation. This agent is almost exclusively excreted by the kidneys and is potentially nephrotoxic.

Table 1. Record
IdentifierMLC-T-ONC-014112
FieldOncology and biomedicine
AbbreviationHES
Synonymshydroxyethyl starch; venofundin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014112",
  "term": "Hetastarch",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous administration, hydroxyethyl starch colloid increases blood volume and thus improves circulation. This agent is almost exclusively excreted by the kidneys and is potentially nephrotoxic.",
  "abbreviation": "HES",
  "synonyms": [
    "hydroxyethyl starch",
    "venofundin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hetastarch/"
}

Record 8,464 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.